In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.
In Q3 2020, secondary equity and credit markets rebounded, primary equity and levered finance markets reopened, and the price of risk declined.
Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.
As we head into Q4 2020, the new normal in private capital markets has fully set in, generally defined by prudence and caution, albeit a work in progress.
Observations and measures of how COVID-related events through August 31, 2020, have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.
Quick-hit visual summaries of the leading economic and financial indicators in major economic markets.
Observations and measures of how H1 2020 COVID-related events have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.
VRC continues to identify potential triggering events of the health and financial crisis as we help clients with financial reporting in our preparation of valuations.
Not every company uses the same method for valuation. Recently, VRC and one of its key partners shared insight into their valuation “secret sauce.”
Tracking the socioeconomic disruption of the coronavirus pandemic.